Systematic review and meta-analysis: Omalizumab decreases exacerbation and allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthmaEvid Based Med ebmed-2014-101759Published Online First: 13 March 2014
https://ebm.bmj.com/content/early/2014/03/13/eb-2014-101759.full
Omalizumab allows a step down in daily inhaled corticosteroid dose in adults and children with moderate-to-severe asthma
02.04.2014 15:23